{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:42:21Z","timestamp":1792370541503,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The current study presents the development of a Cetuximab (CTX)-functionalized chitosan\u2013polydopamine (CS\u2013PDA) hydrogel co-delivering calcium ions (Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    ) and Gefitinib (GFT) for EGFR-targeted therapy against esophageal cancer through the induction of Ca\n                    <jats:sup>2+<\/jats:sup>\n                    mediated cell death and potential immune modulatory effects. FTIR analysis confirmed the functional groups present in the fabricated hydrogel, while UV\u2013Vis spectroscopy verified successful drug incorporation, and SEM analysis revealed a porous morphology suitable for efficient drug encapsulation. The hydrogel shows high drug loading efficiencies of 78.5\u2009\u00b1\u20092.3% for Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    and 81.6\u2009\u00b1\u20093.1% for GFT, with pH-responsive drug release reaching up to 70% under acidic conditions. NIR-activated CTX-CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT hydrogel showed superior cytotoxicity in KYSE-140 cells, with significantly lower IC\u2085\u2080 values than free GFT. Further, JC-1 and AO\/EB staining confirmed mitochondrial depolarization and apoptosis induction, while flow cytometry demonstrated that CTX-CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT\u2009+\u2009NIR markedly induced apoptosis in KYSE-140 cells by combining EGFR inhibition, Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    -mediated stress, and NIR-enhanced ROS generation, resulting in reduced cell viability and increased apoptotic populations. Calcium imaging further validated intracellular Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    accumulation indicated enhanced Ca\n                    <jats:sup>2+<\/jats:sup>\n                    mediated cellular stress in treated cells. In vivo evaluation in a xenograft mouse model revealed tumor inhibition rates of 42%, 24%, 60%, 78%, and 92% for GFT, CS-pDA, CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT, CTX-CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT, and CTX-CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT\u2009+\u2009NIR, respectively. The NIR-activated CTX-CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT formulation achieved the most pronounced tumor regression with negligible impact on body weight, confirming its superior therapeutic efficacy and biosafety. Biochemical analyses of serum ALP, SGOT, urea, and creatinine levels confirmed the biocompatibility and safety of the fabricated hydrogel. Histopathological examination of excised tumor tissues supported the induction of apoptosis and tissue necrosis in treated groups. Furthermore, qRT-PCR and Western blot analyses demonstrated upregulation of Bax and cleaved caspase-3 and downregulation of Bcl-2 and EGFR\/p-AKT signaling, supporting the dual mechanism of action. Besides, CTX-CS-pDA@Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    \/GFT\u2009+\u2009NIR significantly upregulated pro-inflammatory cytokines (IL-6, TNF-\u03b1, and IFN-\u03b3), indicating potential immunomodulatory activity associated with cytokine expression changes driven by targeted delivery, Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    -mediated stress, and NIR-triggered activation. Overall, this multifunctional hydrogel demonstrates strong potential as a localized and targeted therapeutic strategy for EGFR-overexpressing esophageal cancer through synergistic EGFR inhibition, Ca\n                    <jats:sup>2 +<\/jats:sup>\n                    -mediated cytotoxicity, and potential immunomodulatory effects.\n                  <\/jats:p>","DOI":"10.1186\/s13036-026-00726-w","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:13:09Z","timestamp":1784736789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NIR-responsive cetuximab-functionalized chitosan\u2013polydopamine hydrogel Co- delivering Ca2+ and gefitinib for EGFR-targeted esophageal cancer therapy via Ca2+- mediated cytotoxicity and potential immunomodulatory effects"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"3","key":"726_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clinicians"},{"key":"726_CR2","doi-asserted-by":"publisher","unstructured":"Zhu H, Ma X, Ye T, Wang H, Wang Z, Liu Q, Zhao K. Esophageal cancer in China: practice and research in the new era. Int. J. Cancer. 2023;152(9):1741\u201351. https:\/\/doi.org\/10.1002\/ijc.34301.","DOI":"10.1002\/ijc.34301"},{"key":"726_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/life13040892","volume-title":"Endoscopic submucosal dissection for esophageal cancer: current and future","author":"Y Okubo","year":"2023","unstructured":"Okubo Y, Ishihara R. Endoscopic submucosal dissection for esophageal cancer: current and future. MDPI; 2023. https:\/\/doi.org\/10.3390\/life13040892"},{"key":"726_CR4","doi-asserted-by":"publisher","unstructured":"Wang Y, Yang W, Wang Q, Zhou Y. Mechanisms of esophageal cancer metastasis and treatment progress. Front Immunol Front Media S.A. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1206504","DOI":"10.3389\/fimmu.2023.1206504"},{"issue":"12","key":"726_CR5","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.3390\/cancers","volume":"13","author":"C Gronnier","year":"2021","unstructured":"Gronnier C, Collet D. New trends in esophageal cancer management. 2021. Cancers. 2021;13(12):3030. https:\/\/doi.org\/10.3390\/cancers","journal-title":"Cancers"},{"key":"726_CR6","doi-asserted-by":"publisher","unstructured":"Rajagopal D, MacLeod E, Corogeanu D, Vessillier S. Immune-related adverse events of antibody-based biological medicines in cancer therapy. In: J. Cell. Mol. Med. John Wiley and Sons Inc; 2024. https:\/\/doi.org\/10.1111\/jcmm.18470","DOI":"10.1111\/jcmm.18470"},{"key":"726_CR7","doi-asserted-by":"publisher","unstructured":"Abdellatif AAH, Ibrahim MA, Amin MA, Maswadeh H, Alwehaibi MN, Al-Harbi SN, et al. Cetuximab conjugated with octreotide and entrapped calcium Alginate-beads for targeting somatostatin receptors. Sci Rep Nat Res. 2020, 10;10(1). https:\/\/doi.org\/10.1038\/s41598-020-61605-y","DOI":"10.1038\/s41598-020-61605-y"},{"issue":"4","key":"726_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejon.2010.03.004","volume":"14","author":"J Ouwerkerk","year":"2010","unstructured":"Ouwerkerk J, Boers-Doets C. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer. Eur J Oncol Nurs. Churchill Livingstone. 2010;14(4):337\u201349. https:\/\/doi.org\/10.1016\/j.ejon.2010.03.004","journal-title":"Eur J Oncol Nurs. Churchill Livingstone"},{"key":"726_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9050052","volume-title":"Epidermal growth factor receptor cell proliferation signaling pathways","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). MDPI AG; 2017. https:\/\/doi.org\/10.3390\/cancers9050052"},{"issue":"7","key":"726_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09553002.2018.1478160","volume":"94","author":"P Bhattacharya","year":"2018","unstructured":"Bhattacharya P, Shetake NG, Pandey BN, Kumar A. Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization. Int J Radiat Biol. 2018;94(7):628\u201344. https:\/\/doi.org\/10.1080\/09553002.2018.1478160","journal-title":"Int J Radiat Biol"},{"key":"726_CR11","doi-asserted-by":"publisher","unstructured":"Kashyap MK, Abdel-Rahman O. Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma. Mol Cancer. 2018;17(1). https:\/\/doi.org\/10.1186\/s12943-018-0790-4","DOI":"10.1186\/s12943-018-0790-4"},{"issue":"3","key":"726_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ijrobp.2003.08.035","volume":"58","author":"L Milas","year":"2004","unstructured":"Milas L, Fan Z, Andratschke NH, Ang KK. Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies. Int J Radiat Oncol*Biol*Phys. 2004;58(3):966\u201371. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.08.035","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"726_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.radonc.2004.12.021","volume-title":"The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis","author":"J Giralt","year":"2005","unstructured":"Giralt J, De Las Heras M, Cerezo L, Eraso A, Hermosilla E, Velez D, et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis. Radiotherapy and Oncology. Vol. 74. Elsevier Ireland Ltd; 2005. p. 101\u201308. https:\/\/doi.org\/10.1016\/j.radonc.2004.12.021"},{"issue":"5","key":"726_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0360-3016(02)03752-5","volume":"54","author":"J Giralt","year":"2002","unstructured":"Giralt J, Eraso A, Armengol M, Rossell\u00f3 JR, Maj\u00f3 JM, Ares C, et al. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. 2002. Int J Radiat Oncol*Biol*Phys. 2002;54(5):1460\u201365. https:\/\/doi.org\/10.1016\/S0360-3016(02)03752-5","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"19","key":"726_CR15","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.3390\/cancers14194894","volume":"14","author":"J Xue","year":"2022","unstructured":"Xue J, Li B, Wang Y, Huang Z, Liu X, Guo C, et al. Efficacy and safety of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor combination therapy as First-line treatment for patients with advanced EGFR-Mutated, non-small cell Lung cancer: a systematic Review and bayesian network meta-analysis. Cancers (Basel) MDPI. 2022;14(19):4894. https:\/\/doi.org\/10.3390\/cancers14194894","journal-title":"Cancers (Basel) MDPI"},{"key":"726_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030454","volume-title":"Minerals and human health: from deficiency to toxicity","author":"MS Razzaque","year":"2025","unstructured":"Razzaque MS, Wimalawansa SJ. Minerals and human health: from deficiency to toxicity. Nutrients. Multidisciplinary Digital Publishing Institute (MDPI); 2025. https:\/\/doi.org\/10.3390\/nu17030454"},{"key":"726_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121051","volume-title":"Hypercalcemia in cancer: causes, effects, and treatment strategies. Cells","author":"P Bartkiewicz","year":"2024","unstructured":"Bartkiewicz P, Kunachowicz D, Filipski M, Stebel A, Ligoda J, Rembia\u0142kowska N. Hypercalcemia in cancer: causes, effects, and treatment strategies. Cells. Multidisciplinary Digital Publishing Institute (MDPI); 2024. https:\/\/doi.org\/10.3390\/cells13121051"},{"key":"726_CR18","doi-asserted-by":"publisher","unstructured":"Zhang X, Siclari VA, Lan S, Zhu J, Koyama E, Dupuis HL, et al. The critical role of the epidermal growth factor receptor in endochondral ossification. In: Journal of bone and mineral research. Vol. 26. John Wiley and Sons Inc; 2011. p. 2622\u201333. https:\/\/doi.org\/10.1002\/jbmr.502","DOI":"10.1002\/jbmr.502"},{"key":"726_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph17101260","volume-title":"Advances in chitosan-based Smart hydrogels for colorectal cancer treatment. Pharmaceuticals","author":"U Piotrowska","year":"2024","unstructured":"Piotrowska U, Orzechowska K. Advances in chitosan-based Smart hydrogels for colorectal cancer treatment. Pharmaceuticals. Multidisciplinary Digital Publishing Institute (MDPI); 2024. https:\/\/doi.org\/10.3390\/ph17101260"},{"key":"726_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.carbpol.2019.115308","volume":"226","author":"SO Solomevich","year":"2019","unstructured":"Solomevich SO, Bychkovsky PM, Yurkshtovich TL, Golub N V, Mirchuk PY, Revtovich MY, et al. Biodegradable pH-sensitive prospidine-loaded dextran phosphate based hydrogels for local tumor therapy. Carbohyd Polym. 2019;226:226. https:\/\/doi.org\/10.1016\/j.carbpol.2019.115308","journal-title":"Carbohyd Polym"},{"key":"726_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ijbiomac.2020.12.161","volume":"170","author":"B Reig-Vano","year":"2021","unstructured":"Reig-Vano B, Tylkowski B, Montan\u00e9 X, Giamberini M. Alginate-based hydrogels for cancer therapy and research. Int J Biol Macromolecules. 2021;170:424\u201336. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.161","journal-title":"Int J Biol Macromolecules"},{"issue":"38","key":"726_CR22","doi-asserted-by":"publisher","first-page":"42812","DOI":"10.1021\/acsami.2c05864","volume":"14","author":"VHG Phan","year":"2022","unstructured":"Phan VHG, Murugesan M, Huong H, Le TT, Phan TH, Manivasagan P, et al. Cellulose nanocrystals-incorporated thermosensitive hydrogel for controlled release, 3D printing, and breast cancer treatment applications. ACS Appl Mater Interface. 2022;14(38):42812\u201326. https:\/\/doi.org\/10.1021\/acsami.2c05864","journal-title":"ACS Appl Mater Interface"},{"key":"726_CR23","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00289-021-03638-5","volume-title":"Engineering of 3D polymer network hydrogels for biomedical applications: a review. Polymer bulletin","author":"SA Khan","year":"2022","unstructured":"Khan SA, Shah LA, Shah M, Jamil I. Engineering of 3D polymer network hydrogels for biomedical applications: a review. Polymer bulletin. Springer Science and Business Media Deutschland GmbH; 2022. p. 2685\u2013705. https:\/\/doi.org\/10.1007\/s00289-021-03638-5"},{"issue":"5","key":"726_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/md20050335","volume":"20","author":"P Mura","year":"2022","unstructured":"Mura P, Maestrelli F, Cirri M, Mennini N. Multiple roles of chitosan in mucosal drug delivery: an updated Review. Mar Drugs. 2022;20(5):335. https:\/\/doi.org\/10.3390\/md20050335","journal-title":"Mar Drugs"},{"issue":"14","key":"726_CR25","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.3390\/ijms23147909","volume":"23","author":"C Li","year":"2022","unstructured":"Li C, Cheng Y, Li D, An Q, Zhang W, Zhang Y, et al. Antitumor applications of photothermal agents and photothermal synergistic therapies. IJMS. 2022;23(14):7909. https:\/\/doi.org\/10.3390\/ijms23147909","journal-title":"IJMS"},{"key":"726_CR26","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.2147\/IJN.S388996","volume":"Volume 17","author":"C Kong","year":"2022","unstructured":"Kong C, Chen X. Combined Photodynamic and photothermal therapy and Immunotherapy for cancer treatment: a Review. IJN. 2022;Volume 17:6427\u201346. https:\/\/doi.org\/10.2147\/IJN.S388996","journal-title":"IJN"},{"key":"726_CR27","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.2147\/IJN.S514659","volume":"Volume 20","author":"R Zhao","year":"2025","unstructured":"Zhao R, Li S, Zhao J, Yao C. Advancements in Nano-delivery systems for Photodynamic and photothermal therapy to induce immunogenic cell death in tumor Immunotherapy. IJN. 2025;Volume 20:8221\u201348. https:\/\/doi.org\/10.2147\/IJN.S514659","journal-title":"IJN"},{"key":"726_CR28","doi-asserted-by":"publisher","unstructured":"Fan S, Lin W, Huang Y, Xia J, Xu JF, Zhang J, et al. Advances and potentials of polydopamine nanosystem in photothermal-based antibacterial infection therapies. Front Pharmacol Front Media S.A. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.829712","DOI":"10.3389\/fphar.2022.829712"},{"key":"726_CR29","doi-asserted-by":"publisher","unstructured":"Breitwieser GE. Extracellular calcium as an integrator of tissue function. Int J Biochem & Cell Biol. 2008;40(8):1467\u201380. https:\/\/doi.org\/10.1016\/j.biocel.2008.01.019.","DOI":"10.1016\/j.biocel.2008.01.019"},{"key":"726_CR30","doi-asserted-by":"publisher","unstructured":"Mao Y, Du X, Wang W, Dong T, Zhu M, Niu J, et al. Melanin@PLGA\/nuciferine nanoparticles for enhanced photothermal therapy of hepatocellular carcinoma by promoting autophagy. Int J Nanomed. 2025;20:11081-97. https:\/\/doi.org\/10.2147\/IJN.S536620.","DOI":"10.2147\/IJN.S536620"},{"issue":"1","key":"726_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1208\/s12248-015-9836-3","volume":"18","author":"Y Bi","year":"2016","unstructured":"Bi Y, Deng J, Murry DJ, An G. A whole-body physiologically based pharmacokinetic model of gefitinib in mice and scale-up to humans. AAPS J Springer New Y LLC. 2016;18(1):228\u201338. https:\/\/doi.org\/10.1208\/s12248-015-9836-3","journal-title":"AAPS J Springer New Y LLC"},{"issue":"1","key":"726_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1756-0500-4-140","volume":"4","author":"T Matsuo","year":"2011","unstructured":"Matsuo T, Nishizuka SS, Ishida K, Iwaya T, Ikeda M, Wakabayashi G. Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models. BMC Res Notes. 2011;4(1):4. https:\/\/doi.org\/10.1186\/1756-0500-4-140","journal-title":"BMC Res Notes"},{"issue":"10","key":"726_CR33","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.7150\/thno.97335","volume":"14","author":"M Wu","year":"2024","unstructured":"Wu M, Liu H, Zhu Y, Wu P, Chen Y, Deng Z, et al. Bioinspired soft-hard combined system with mild photothermal therapeutic activity promotes diabetic bone defect healing via synergetic effects of immune activation and angiogenesis. Theranostics. Ivyspring Int Publisher. 2024;14(10):4014\u201357. https:\/\/doi.org\/10.7150\/thno.97335","journal-title":"Theranostics. Ivyspring Int Publisher"},{"issue":"1","key":"726_CR34","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jmrt.2018.03.007","volume":"8","author":"A Raza","year":"2019","unstructured":"Raza A, Hayat U, Rasheed T, Bilal M, Iqbal HMN. \u201cSmart\u201d materials-based near-infrared light-responsive drug delivery systems for cancer treatment: a review. J Mater Res Technol Elsevier Editora Ltda. 2019;8(1):1497\u2013509. https:\/\/doi.org\/10.1016\/j.jmrt.2018.03.007","journal-title":"J Mater Res Technol Elsevier Editora Ltda"},{"key":"726_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.actbio.2016.04.024","volume":"38","author":"Q Feng","year":"2016","unstructured":"Feng Q, Zhang Y, Zhang W, Shan X, Yuan Y, Zhang H, et al. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Acta Biomater. 2016;38:129\u201342. https:\/\/doi.org\/10.1016\/j.actbio.2016.04.024","journal-title":"Acta Biomater"},{"key":"726_CR36","doi-asserted-by":"publisher","unstructured":"Ge RL, Yan PN, Liu Y, Li ZS, Shen SQ, Yu Y. Recent Advances and Clinical potential of near infrared photothermal conversion materials for photothermal hepatocellular carcinoma therapy. In: Adv. Funct. Mater. John Wiley and Sons Inc; 2023. https:\/\/doi.org\/10.1002\/adfm.202301138","DOI":"10.1002\/adfm.202301138"},{"key":"726_CR37","doi-asserted-by":"publisher","unstructured":"Egnuni T, Ingram N, Mirza I, Coletta PL, McLaughlan JR. Evaluation of the targeting and therapeutic efficiency of anti-egfr functionalised nanoparticles in head and neck cancer cells for use in nir-ii optical window. Pharm MDPI. 2021;13. https:\/\/doi.org\/10.3390\/pharmaceutics13101651","DOI":"10.3390\/pharmaceutics13101651"},{"key":"726_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.22037\/ijpr.2020.113439.14303","volume":"20","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang XM, Sun Y, Chen HL, Zhou LY. Cetuximab-decorated and NIR-activated nanoparticles based on Platinum(IV)-prodrug: preparation, characterization and in-vitro anticancer activity in epidermoid carcinoma cells. Iran J Pharm Res Brieflands. 2021;20:371\u201383. https:\/\/doi.org\/10.22037\/ijpr.2020.113439.14303","journal-title":"Iran J Pharm Res Brieflands"},{"key":"726_CR39","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2217\/nnm-2022-0064","volume-title":"Synergistic chemo-photothermal and ferroptosis therapy of polydopamine nanoparticles for esophageal cancer","author":"Y Chen","year":"2022","unstructured":"Chen Y, Su M, Jia L, Zhang Z. Synergistic chemo-photothermal and ferroptosis therapy of polydopamine nanoparticles for esophageal cancer. Vol. 17. Nanomedicine. Newlands Press Ltd; 2022. p. 1115\u201330. https:\/\/doi.org\/10.2217\/nnm-2022-0064"},{"key":"726_CR40","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.2147\/IJN.S473473","volume":"19","author":"F Fang","year":"2024","unstructured":"Fang F, Chen YY, Zhang XM, Tang J, Liu YH, Peng CS, et al. EGFR-Targeted and NIR-Triggered lipid-polymer hybrid nanoparticles for chemo-photothermal colorectal tumor therapy. IJN. 2024;19:9689\u2013705. https:\/\/doi.org\/10.2147\/IJN.S473473","journal-title":"IJN"},{"issue":"10","key":"726_CR41","doi-asserted-by":"publisher","first-page":"8982","DOI":"10.3390\/ijms24108982","volume":"24","author":"DO Moon","year":"2023","unstructured":"Moon DO. Calcium\u2019s role in orchestrating cancer apoptosis: mitochondrial-centric perspective. Int J Mol Sci. 2023;24(10):8982. https:\/\/doi.org\/10.3390\/ijms24108982","journal-title":"IJMS"},{"key":"726_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10565-025-10116-5","volume-title":"Dual-functional Mo\u2082N nanomaterials for photothermal therapy: enhancing MRSA-infected wound healing and selective thyroid cancer ablation. Cell Biol Toxicol","author":"W Zhang","year":"2026","unstructured":"Zhang W, Wu S, Chen C. Dual-functional Mo\u2082N nanomaterials for photothermal therapy: enhancing MRSA-infected wound healing and selective thyroid cancer ablation. Cell Biol Toxicol. Springer Science and Business Media B.V; 2026. p. 42. https:\/\/doi.org\/10.1007\/s10565-025-10116-5"},{"issue":"23","key":"726_CR43","doi-asserted-by":"publisher","first-page":"20316","DOI":"10.1074\/jbc.M006492200","volume":"276","author":"CS Adams","year":"2001","unstructured":"Adams CS, Mansfield K, Perlot RL, Shapiro IM. Matrix regulation of skeletal cell apoptosis. Role of calcium and phosphate ions. J Biol Chem. 2001;276(23):20316\u201322. https:\/\/doi.org\/10.1074\/jbc.M006492200","journal-title":"J Biol Chem"},{"key":"726_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/cancers14205043","volume-title":"Molecularly targeted photothermal ablation of epidermal growth factor receptor-expressing cancer cells with a Polypyrrole-Iron oxide-Afatinib Nanocomposite","author":"L Rethi","year":"2022","unstructured":"Rethi L, Mutalik C, Rethi L, Chiang WH, Lee HL, Pan WY, et al. Molecularly targeted photothermal ablation of epidermal growth factor receptor-expressing cancer cells with a Polypyrrole-Iron oxide-Afatinib Nanocomposite. Cancers (Basel). MDPI; 2022. p. 14. https:\/\/doi.org\/10.3390\/cancers14205043"},{"key":"726_CR45","doi-asserted-by":"publisher","unstructured":"Ma Z, Zhang J, Zhang W, Foda MF, Zhang Y, Ge L, et al. Intracellular Ca2+ cascade guided by NIR-II photothermal switch for specific tumor therapy. Iscience. 2020;23(5). https:\/\/doi.org\/10.1016\/j.isci.2020.101049.","DOI":"10.1016\/j.isci.2020.101049"},{"key":"726_CR46","doi-asserted-by":"publisher","unstructured":"Chen Q, Huo D, Cheng H, Lyu Z, Zhu C, Guan B, et al. Near\u2010infrared\u2010triggered release of Ca2+ ions for potential application in combination cancer therapy. Adv Healthc Mater. 2019;8(6):1801113. https:\/\/doi.org\/10.1002\/adhm.201801113.","DOI":"10.1002\/adhm.201801113"},{"key":"726_CR47","doi-asserted-by":"publisher","unstructured":"Shao F, Han J, Tian Z, Wang Z, Liu S, Wu Y. Synergistic ROS generation and directional overloading of endogenous calcium induce mitochondrial dysfunction in living cells. Biomater Elsevier Ltd. 2023;301. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122284","DOI":"10.1016\/j.biomaterials.2023.122284"},{"key":"726_CR48","doi-asserted-by":"publisher","unstructured":"Wang J, Wang W, Shen Q, Lan L, Guan C, Xu X, et al. Cell-surface photochemistry mediated calcium overload for synergistic tumor therapy. J Nanobiotechnol Biomed Central Ltd. 2023, 21;21(1). https:\/\/doi.org\/10.1186\/s12951-023-02090-z","DOI":"10.1186\/s12951-023-02090-z"},{"issue":"1","key":"726_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41467-021-26655-4","volume":"12","author":"W Bao","year":"2021","unstructured":"Bao W, Liu M, Meng J, Liu S, Wang S, Jia R, et al. Mofs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload. Nat Commun Nat Res. 2021;12(1):12. https:\/\/doi.org\/10.1038\/s41467-021-26655-4","journal-title":"Nat Commun Nat Res"},{"key":"726_CR50","doi-asserted-by":"publisher","unstructured":"Yang F, Luo N, Ren L, Ding W, Wu X. Smart biodegradable hydrogels incorporating a photoactive Ir(III) complex for NIR-triggered oral cancer treatment. Cancer Nanotechnol Biomed Central Ltd. 2025, 16;16(1). https:\/\/doi.org\/10.1186\/s12645-025-00336-z","DOI":"10.1186\/s12645-025-00336-z"},{"issue":"1","key":"726_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12951-023-02220-7","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C, Li T, Wang Z, Li Y, Liu Y, Xu M, et al. Nano-modulators with the function of disrupting mitochondrial Ca2+ homeostasis and photothermal conversion for synergistic breast cancer therapy. J Nanobiotechnol Biomed Central Ltd. 2023;21(1):21. https:\/\/doi.org\/10.1186\/s12951-023-02220-7","journal-title":"J Nanobiotechnol Biomed Central Ltd"},{"key":"726_CR52","doi-asserted-by":"publisher","unstructured":"Zhang M, Ran S, Yin X, Zhang J, Sun X, Sun W, Zhu Z. Mesoporous polydopamine nanoplatforms loaded with calcium ascorbate for amplified oxidation and photothermal combination cancer therapy. BMEMat. 2023;1(4):e12041. https:\/\/doi.org\/10.1002\/bmm2.12041.","DOI":"10.1002\/bmm2.12041"},{"key":"726_CR53","doi-asserted-by":"publisher","first-page":"102320","DOI":"10.1016\/j.mtbio.2025.102320","volume":"35","author":"Q Gong","year":"2025","unstructured":"Gong Q, Shi L, Wen L, Zhang Y, Chen Z, Wei X, et al. Recent advances in metal ions overloading for tumors: mechanisms, nanomaterials, and therapies. Mater Today Bio. 2025;35:102320. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102320","journal-title":"Mater Today Bio"},{"key":"726_CR54","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.2147\/IJN.S464981","volume":"19","author":"B Zhang","year":"2024","unstructured":"Zhang B, Man J, Guo L, Ru X, Zhang C, Liu W, et al. Layer-by-layer nanoparticles for calcium overload in situ enhanced reactive oxygen oncotherapy. IJN. 2024;19:7307\u201321. https:\/\/doi.org\/10.2147\/IJN.S464981","journal-title":"IJN"},{"issue":"12","key":"726_CR55","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/genes13122183","volume":"13","author":"S Nishihara","year":"2022","unstructured":"Nishihara S, Yamaoka T, Ishikawa F, Higuchi K, Hasebe Y, Manabe R, et al. Mechanisms of EGFR-TKI-Induced apoptosis and strategies targeting apoptosis in EGFR-Mutated non-Small cell Lung cancer. Genes (Basel) MDPI. 2022;13(12):2183. https:\/\/doi.org\/10.3390\/genes13122183","journal-title":"Genes (Basel) MDPI"},{"issue":"24","key":"726_CR56","doi-asserted-by":"publisher","first-page":"13727","DOI":"10.3390\/ijms252413727","volume":"25","author":"A Gieleci\u0144ska","year":"2024","unstructured":"Gieleci\u0144ska A, Kciuk M, Kontek R. The impact of calcium overload on cellular processes: exploring Calcicoptosis and its therapeutic potential in cancer. IJMS. 2024;25(24):13727. https:\/\/doi.org\/10.3390\/ijms252413727","journal-title":"IJMS"},{"key":"726_CR57","doi-asserted-by":"publisher","unstructured":"Bagheri-Mohammadi S, Farjami M, Suha AJ, Zarch SMA, Najafi S, Esmaeili A. The mitochondrial calcium signaling, regulation, and cellular functions: a novel target for therapeutic medicine in neurological disorders. In: J. Cell. Biochem. John Wiley and Sons Inc; 2023. p. 635\u201355. https:\/\/doi.org\/10.1002\/jcb.30414","DOI":"10.1002\/jcb.30414"},{"key":"726_CR58","doi-asserted-by":"publisher","unstructured":"Bauer TM, Murphy E. Role of mitochondrial calcium and the permeability transition pore in regulating cell death. In: Circ. Res. Lippincott Williams and Wilkins; 2020. p. 280\u201393. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316306","DOI":"10.1161\/CIRCRESAHA.119.316306"},{"issue":"5","key":"726_CR59","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/antiox11051034","volume":"11","author":"O Cantoni","year":"2022","unstructured":"Cantoni O, Zito E, Guidarelli A, Fiorani M, Ghezzi GP. Mitochondrial ROS, ER stress, and Nrf2 Crosstalk in the regulation of mitochondrial apoptosis induced by Arsenite. Antioxid MDPI. 2022;11(5):1034. https:\/\/doi.org\/10.3390\/antiox11051034","journal-title":"Antioxid MDPI"},{"issue":"11","key":"726_CR60","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3390\/cancers13112748","volume":"13","author":"ML Uribe","year":"2021","unstructured":"Uribe ML, Marrocco I, Yarden Y. EGFR in cancer: signaling mechanisms, drugs, and acquired Resistance. Cancers. 2021;13(11):2748. https:\/\/doi.org\/10.3390\/cancers13112748","journal-title":"Cancers"},{"key":"726_CR61","doi-asserted-by":"publisher","DOI":"10.34172\/bi.30905","volume-title":"Potential role of epidermal growth factor receptors (EGFR) signaling in the pathogenesis and management of hepatocellular carcinoma. BioImpacts","author":"SSA Al-Awadhi","year":"2025","unstructured":"Al-Awadhi SSA, Patil P, Shetty P, Shetty PK, Shetty RA, Shetty V V. Potential role of epidermal growth factor receptors (EGFR) signaling in the pathogenesis and management of hepatocellular carcinoma. BioImpacts. Tabriz University of Medical Sciences; 2025. https:\/\/doi.org\/10.34172\/bi.30905"},{"issue":"5","key":"726_CR62","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3892\/ijo.2011.1320","volume":"40","author":"LJ Xiao","year":"2012","unstructured":"Xiao LJ, Lin P, Lin F, Liu X, Qin W, Zou HF, et al. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol. 2012;40(5):1714\u201324. https:\/\/doi.org\/10.3892\/ijo.2011.1320","journal-title":"Int J Oncol"},{"key":"726_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.20517\/cdr.2023.145","volume-title":"Dysregulation of calcium homeostasis in cancer and its role in chemoresistance. Cancer drug Resistance","author":"N Kumari","year":"2024","unstructured":"Kumari N, Pullaguri N, Rath SN, Bajaj A, Sahu V, Ealla KKR. Dysregulation of calcium homeostasis in cancer and its role in chemoresistance. Cancer drug Resistance. OAE Publishing Inc; 2024. p. 7. https:\/\/doi.org\/10.20517\/cdr.2023.145"},{"issue":"9","key":"726_CR64","doi-asserted-by":"publisher","first-page":"7541","DOI":"10.1021\/acsami.7b08392","volume":"10","author":"R Mrowczynski","year":"2018","unstructured":"Mrowczynski R. Polydopamine-based multifunctional (Nano)materials for cancer therapy. ACS Appl Mater Interface Am Chem Soc. 2018;10(9):7541\u201361. https:\/\/doi.org\/10.1021\/acsami.7b08392","journal-title":"ACS Appl Mater Interface Am Chem Soc"},{"key":"726_CR65","doi-asserted-by":"publisher","unstructured":"Chen ZS, Tian D, Liao X, Zhang Y, Xiao J, Chen W, et al. Apigenin combined with gefitinib blocks autophagy flux and induces apoptotic cell death through inhibition of HIF-1\u03b1, c-myc, p-EGFR, and glucose metabolism in EGFR L858R+T790M-Mutated H1975 cells. Front Pharmacol Front Media S.A. 2019;10. https:\/\/doi.org\/10.3389\/fphar.2019.00260","DOI":"10.3389\/fphar.2019.00260"},{"key":"726_CR66","doi-asserted-by":"publisher","unstructured":"Zhou Y, Jing S, Liu S, Shen X, Cai L, Zhu C, et al. Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy. J Nanobiotechnol Biomed Central Ltd. 2022, 20;20(1). https:\/\/doi.org\/10.1186\/s12951-022-01392-y","DOI":"10.1186\/s12951-022-01392-y"},{"issue":"2","key":"726_CR67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1021\/acs.biomac.9b01290","volume":"21","author":"P Sun","year":"2020","unstructured":"Sun P, Huang T, Wang X, Wang G, Liu Z, Chen G, et al. Dynamic-covalent hydrogel with NIR-Triggered drug delivery for localized chemo-photothermal combination therapy. Biomacromolecules Am Chem Soc. 2020;21(2):556\u201365. https:\/\/doi.org\/10.1021\/acs.biomac.9b01290","journal-title":"Biomacromolecules Am Chem Soc"},{"key":"726_CR68","doi-asserted-by":"publisher","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. In: Arch. Toxicol. Springer Science and Business Media Deutschland GmbH; 2023. p. 1439\u201351. https:\/\/doi.org\/10.1007\/s00204-023-03476-6","DOI":"10.1007\/s00204-023-03476-6"},{"issue":"5","key":"726_CR69","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/ma16052073","volume":"16","author":"C Thambiliyagodage","year":"2023","unstructured":"Thambiliyagodage C, Jayanetti M, Mendis A, Ekanayake G, Liyanaarachchi H, Vigneswaran S. Recent Advances in chitosan-based applications\u2014A Review. Mater MDPI. 2023;16(5):2073. https:\/\/doi.org\/10.3390\/ma16052073","journal-title":"Mater MDPI"},{"key":"726_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/gels11030190","volume-title":"Polydopamine Nanocomposite hydrogel for drug slow-release in Bone defect repair: a Review of Research Advances. Gels","author":"X Li","year":"2025","unstructured":"Li X, Tang J, Guo W, Dong X, Cao K, Tang F. Polydopamine Nanocomposite hydrogel for drug slow-release in Bone defect repair: a Review of Research Advances. Gels. Multidisciplinary Digital Publishing Institute (MDPI); 2025.https:\/\/doi.org\/10.3390\/gels11030190"},{"issue":"6","key":"726_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/gels9060452","volume":"9","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wu H, Wang S, Zhao J, Hu L. Preparation and characterization of biocompatible Iron\/Zirconium\/Polydopamine\/Carboxymethyl chitosan hydrogel with Fenton catalytic properties and photothermal efficacy. Gels. MDPI. 2023;9(6):9. https:\/\/doi.org\/10.3390\/gels9060452","journal-title":"Gels. MDPI"},{"key":"726_CR72","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2024.08.014","volume":"374","author":"H Zhang","year":"2024","unstructured":"Zhang H, Wang X, Yang X, Wu Z, Chen Q, Wei Q, et al. NIR-triggered and Thermoresponsive core-shell nanoparticles for synergistic anticancer therapy. J Control Release. Elsevier B.V. 2024;374:194\u2013204. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.014","journal-title":"J Control Release. Elsevier B.V"},{"key":"726_CR73","doi-asserted-by":"publisher","unstructured":"ChenLiu Z, Gu C, Wang L, Wu Q, Tang D. Nanocarrier-mediated photothermal therapy and its combined strategies: mechanism exploration and application in tumour treatment. Cancer Nanotechnol Biomed Central Ltd. 2025;16(1). https:\/\/doi.org\/10.1186\/s12645-025-00349-8","DOI":"10.1186\/s12645-025-00349-8"},{"key":"726_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5040-z","volume-title":"Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials","author":"ZH Huang","year":"2018","unstructured":"Huang ZH, Ma XW, Zhang J, Li X, Lai NL, Zhang SX. Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials. BMC Cancer. BioMed Central Ltd; 2018 18. https:\/\/doi.org\/10.1186\/s12885-018-5040-z"},{"key":"726_CR75","doi-asserted-by":"publisher","unstructured":"Sun M, Wang T, Li L, Li X, Zhai Y, Zhang J, et al. The application of inorganic nanoparticles in molecular targeted cancer therapy: EGFR targeting. Front Pharmacol Front Media S.A. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.702445","DOI":"10.3389\/fphar.2021.702445"},{"key":"726_CR76","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jphotobiol.2017.03.025","volume":"170","author":"M Zhang","year":"2017","unstructured":"Zhang M, Kim HS, Jin T, Moon WK. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer. J Photochem Photobiol B. 2017;170:58\u201364. https:\/\/doi.org\/10.1016\/j.jphotobiol.2017.03.025","journal-title":"J Photochem Photobiol B"},{"key":"726_CR77","doi-asserted-by":"publisher","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct. Target. Ther. Springer Nature 2021. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","DOI":"10.1038\/s41392-021-00828-5"},{"issue":"12","key":"726_CR78","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","volume":"1","author":"MM Georgescu","year":"2010","unstructured":"Georgescu MM. Pten tumor suppressor network in PI3K-Akt pathway control. Genes Cancer. 2010;1(12):1170\u201377. https:\/\/doi.org\/10.1177\/1947601911407325","journal-title":"Genes Cancer"},{"issue":"6","key":"726_CR79","doi-asserted-by":"publisher","first-page":"118688","DOI":"10.1016\/j.bbamcr.2020.118688","volume":"1867","author":"A Boice","year":"2020","unstructured":"Boice A, Bouchier-Hayes L. Targeting apoptotic caspases in cancer. Biochim et Biophys Acta (BBA) - Mol Cell Res. Elsevier B.V.; 2020. 2020;1867(6):118688. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118688","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"key":"726_CR80","doi-asserted-by":"publisher","unstructured":"Cao R, Jiang H, Chen P, Dai C. Role of depression-mediated alterations in pro-inflammatory cytokines in carcinogenesis. Front Immunol Front Media SA. 2025;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1659153","DOI":"10.3389\/fimmu.2025.1659153"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-026-00726-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:36:03Z","timestamp":1792370163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-026-00726-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1186\/s13036-026-00726-w","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Experimental Animal Ethics Committee of Beijing Jinglai Huake Biotechnology Co., Ltd (NO. JLSW-2023117).","order":1,"name":"Ethics","label":"Ethical statement and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"151"}}